Feed ANIP
AN

ANI Pharmaceuticals, Inc. ANIP · NASDAQ

$72.67 +0.15% (+$0.11)

Market cap
$1.67B
Enterprise value
$1.64B
P/E
15.7x
Forward P/E
8.5x
PEG
-
P/S
1.7x
P/FCF
10.4x
EV/EBITDA
6.4x
ROIC
9.3%
Bruto marža
65.2%
Neto marža
10.8%
Dividend yield
-
Payout ratio
-
Neto dolg/EBITDA
-0.1x
Beta
0.50
Free float
85.7%

O podjetju

ANI Pharmaceuticals, Inc. (ANI) is an American pharmaceutical company specializing in the development, manufacturing, and sale of generic and specialty pharmaceuticals. With a broad portfolio of pharmaceutical products, including generic versions of drug substances and specialty drugs for various therapeutic indications, ANI Pharmaceuticals is a recognized player in the pharmaceutical market. The company focuses on providing affordable and quality medicines for patients and healthcare facilities across the United States. ANI Pharmaceuticals also invests in research and development of new pharmaceutical products and seeks opportunities to expand its portfolio through acquisitions and licenses. ANI Pharmaceuticals, Inc. (ANI) shares could be suitable for investors seeking investment opportunities in the pharmaceutical industry and generic drugs.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Nikhil Lalwani

Employees

970

Headquarters

Baudette

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.